Skip to content
Screener

Savara SVRA Stock-Based Comp

Stock-Based Comp at other companies

Innoviva, Inc. logo
Innoviva, Inc.INVA
$4.74M+95.8%
XER
Xeris Biopharma Holdings, Inc.XERS
$11.07M+121%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$2.97M+20.5%
Upstream Bio, Inc. logo
Upstream Bio, Inc.UPB
$4.35M+67.7%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$11.41M+18.8%
PVL
Palvella TherapeuticsPVLA
$3.38M+209%

Other financials

Income statement

See full
Revenue-
Operating income-$41.0M-30.3%
Net income-$40.2M-32.3%
EPS (diluted)-$0.16-14.3%

Balance sheet

See full
Cash & equivalents$41.8M+140%
Total debt$31.2M+5.2%
Total equity$143.7M+19.2%
Total assets$192.1M+17.3%

Cash flow

See full
Operating cash flow-$29.7M-13.3%
CapEx$222.0K+1,380%
Free cash flow-$30.0M-14.1%

Valuation

See full
Market cap$1.17B+152%
Enterprise value$1.16B+143%

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-105.5%+7.0pp
Debt / equity0.2×0.0×
Current ratio10.1×-0.9×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The source filing: Savara’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-344585
Line itemFor the six months ended June 30, 2026For the six months ended June 30, 2025
Loss on extinguishment of debt546
Change in fair value of royalty agreement derivative liability23
Accretion on discount to short-term investments(987)(1,950)
Stock-based compensation18,4925,641
Changes in operating assets and liabilities:
Prepaid expenses and other current assets8421,739
Non-current assets(864)(768)
Accounts payable and accrued expenses and other current liabilities(3,155)(1,958)

Cover / Front Matter

FAQ

What is Savara's stock-based comp?
Savara (SVRA) reported stock-based comp of $7.77M in Q2 2026.
How has Savara's stock-based comp changed year-over-year?
Savara's stock-based comp increased by 190.9% year-over-year, from $2.67M to $7.77M.
What is the long-term trend for Savara's stock-based comp?
Over 4 years (2021 to 2025), Savara's stock-based comp has grown at a 45.0% compound annual growth rate (CAGR), from $3.26M to $14.42M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Ask your AI about Savara's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude